- New product launches, regulatory approvals, technological advancements, collaborations, and mergers are several strategies adopted by players that are projected to help in the expansion of the hemostasis diagnostics market in the near future
- Surge in prevalence of cardiovascular diseases and blood clotting disorders are anticipated to create lucrative opportunities for companies operating in the market
ALBANY, N.Y., Nov. 8, 2021 /PRNewswire/ -- The rise in the number of populace with different bleeding disorders such as hemophilia is acting as a one of the key drivers for the expansion of the global hemostasis diagnostics market. Hemophilia is a health condition in which an individual's body is unable to create different clotting factors.
According to the Centers for Disease Control and Prevention (CDC), approximately one in 5,000 male babies are born with hemophilia. At present, there are more than 440,000 male patients dealing with the issue of severe hemophilia across the globe. Of them, 75% reside in developing and underdeveloped nations. This factor highlights the potential expansion opportunities for the market players in such countries.
Request Brochure of Hemostasis Diagnostics Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1503
A report by Transparency Market Research (TMR) projects the global hemostasis diagnostics market to grow at a CAGR of 8.5% during the forecast period, from 2019 to 2027.
Hemostasis Diagnostics Market: Key Findings
Rise in Prevalence of Cardiovascular Diseases Boosts Product Demand
Sedentary lifestyle of major share of the world populace and surge in the number of older population have resulted into rise in prevalence of different health issues including cardiovascular diseases, diabetes, cancer, and neurological disorders across several developing nations.
Request for Analysis of COVID-19 Impact on Hemostasis Diagnostics Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1503
As per the statistics by World Health Organization (WHO), cardiovascular disease is the main factor for around 17.5 million deaths across the world, which accounts for approximately 31% of the total deaths worldwide. This increase in the number of cardiac health issues is leading to rise in the demand for hemostasis diagnostics solutions.
Advancements in Hemostasis Technology Result in Easy Operation of Hemostasis Diagnostics Devices
With the growing focus of market players on incorporation of advanced technologies in their products, there is significant advancement in hemostasis diagnostics devices, which perform various functions, including quantification of a clot's optical density in a cuvette as well as the detection of clotting factors. Thus, these developments in the hemostasis technology are helping healthcare professionals to offer precise emergency health services to their patients.
TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1503
Automated hemostasis diagnostics solutions are gaining immense popularity, owing to their several advantages such as rapid, easy-to-use, and less labor intensive operations. Flow cytometers, blood coagulation analyzers, PCR, and microarrays are some of the automation technologies that are used to achieve high levels of precision in the healthcare industry. On the back of this technological revolution in hemostasis diagnostics, the market is estimated to attract prominent growth avenues during the forecast period.
Hemostasis Diagnostics Market: Growth Boosters
- In deep vein thrombosis, a cardiovascular complication, there is formation of blood clots within the deep veins of an individual's legs. Surge in the number of such patients is expected to boost the growth of the global hemostasis diagnostics market in the near future.
- Companies operating in the global hemostasis diagnostics market are focused on execution of different strategies such as development of technologically advanced products, regulatory approvals, new product launches, collaborations, and acquisitions. These activities are helping in market expansion.
Buy Hemostasis Diagnostics Market Research Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1503<ype=S
Hemostasis Diagnostics Market: Regional Analysis
- The North America hemostasis diagnostics market is projected to gain prominent expansion prospects on the back of surge in cases of deep vein thrombosis, genetic and acquired blood clotting disorders, and cardiovascular diseases in the region
- Rise in easy availability of healthcare services, technological advancements, and entry of new players are some of the important factors fueling the growth of the North America hemostasis diagnostics market
- Players are expected to witness exceptional growth opportunities in the Asia Pacific region. Growing focus of several regional government authorities to advance healthcare infrastructure is one of the key factors driving the Asia Pacific hemostasis diagnostics market.
Hemostasis Diagnostics Market: Key Players
Some of the key players operating in the hemostasis diagnostics market are:
- Thermo Fisher Scientific, Inc.
- Abbott Laboratories
- Nihon Kohden Corporation
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers
- Sysmex Corporation
- Danaher Corporation (Beckman Coulter)
- Instrumentation Laboratory
- Grifols
Hemostasis Diagnostics Market Segmentation
Product Type
- Laboratory Systems
- Consumables
- Point-of-Care Testing Systems
Product Type
- Prothrombin Test Time (PT)
- Activated partial thromboplastin time (APTT)
- Fibrinogen degradation products (FDP)
- Activated Clotting Time
- Platelet Aggregation Test
- D Dimer
- Others
End-user
- Hospital/Clinics
- Independent Diagnostic Laboratories
- Home Care Settings
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:
Pressure Ulcer Diagnostics Market: The pressure ulcer diagnostics market is projected to cross US$ 1.49 Bn by 2031. Bullous pemphigoid (BP) is a severe skin disorder with high morbidity and mortality rates. However, as the condition progresses, rendering an accurate diagnosis may be a challenge for clinicians. Hence, practitioners are arriving at a diagnosis of BP by evaluating the clinical manifestations of the disorder and by obtaining a detailed patient history.
Home Diagnostics Market: The global home diagnostics market is observing a high growth rate and expected to continue to expand in the near future due to the rising disposable income of people across nations, which enable them to afford products for self-care.
Radiopharmaceutical Theranostics Market: Companies in the radiopharmaceutical theranostics market are increasing the availability of radioactive medicines through oral, intravenous, and interstitial route to diagnose malignancy. The high prevalence of cancer is acting as a key growth driver of the radiopharmaceutical theranostics market, as radioactive medicines have the ability to destroy cancerous cells by emitting radiation when it reaches the target cell.
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/hemostasis-diagnostics-market.htm
Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg
Share this article